| |
| |
|
| Insider
Information: |
Sinha Vikas |
| Relationship: |
|
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,311,602 |
|
|
Indirect Shares
|
16,674,766 |
|
|
| Direct
Value |
$33,448,133 |
|
|
|
Indirect Value
|
$12,929,614 |
|
|
| Total
Shares |
17,986,368 |
|
|
| Total
Value |
$46,377,747 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
22
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
16
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -752.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP & CFO |
2016-08-08 |
178,463 |
2005-09-21 |
0 |
Premium* |
|
|
Allovir Inc |
ALVR |
|
2024-05-03 |
1,133,139 |
2024-05-03 |
16,674,766 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
144 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2005-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$20.72 |
$82,880 |
D/D |
4,000 |
24,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,706 |
27,706 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• • – |
2007-09-24 |
4 |
AS |
$63.00 |
$263,032 |
D/D |
(4,162) |
28,544 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2008-07-10 |
4 |
S |
$75.75 |
$12,044 |
D/D |
(159) |
31,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
• – – |
2008-08-01 |
4 |
AS |
$92.28 |
$923,520 |
D/D |
(10,000) |
31,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-03-24 |
4 |
S |
$58.21 |
$59,681 |
D/D |
(1,025) |
31,308 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-10 |
4 |
S |
$69.02 |
$49,073 |
D/D |
(711) |
32,333 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
32,706 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & Chief Financial Officer |
• – – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
33,044 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr VP and CFO |
• – – |
2008-08-01 |
4 |
OE |
$27.58 |
$275,800 |
D/D |
10,000 |
41,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-19 |
4 |
S |
$47.22 |
$25,452 |
D/D |
(539) |
46,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-11 |
4 |
S |
$47.68 |
$136,412 |
D/D |
(2,861) |
46,846 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-12-10 |
4 |
S |
$46.00 |
$460,000 |
D/D |
(10,000) |
49,707 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CFO |
• – – |
2010-07-16 |
4 |
S |
$51.08 |
$27,583 |
D/D |
(540) |
53,281 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-07-12 |
4 |
S |
$51.91 |
$25,228 |
D/D |
(486) |
53,821 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,000 |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-02-22 |
4 |
AS |
$50.01 |
$1,500,300 |
D/D |
(30,000) |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2010-03-25 |
4 |
AS |
$55.00 |
$1,100,000 |
D/D |
(20,000) |
54,307 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-16 |
4 |
S |
$36.84 |
$61,191 |
D/D |
(1,661) |
58,197 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-09-22 |
4 |
S |
$46.27 |
$84,813 |
D/D |
(1,833) |
59,707 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2009-01-12 |
4 |
S |
$34.48 |
$12,930 |
D/D |
(375) |
59,858 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Sr. VP & CFO |
• – – |
2008-09-22 |
4 |
S |
$41.37 |
$85,429 |
D/D |
(2,065) |
60,233 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-16 |
4 |
S |
$38.96 |
$15,467 |
D/D |
(397) |
61,540 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP & CFO |
• – – |
2009-07-10 |
4 |
S |
$36.93 |
$11,744 |
D/D |
(318) |
61,937 |
0 |
- |
|
144 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
